ARA-290

ARA-290 (Cibinetide) is a synthetic peptide developed from erythropoietin (EPO), specifically designed to activate the body’s Innate Repair Receptor (IRR) while avoiding stimulation of red blood cell formation. It has become the focus of extensive research due to its potential benefits in nerve regeneration, managing neuropathy, reducing inflammation, protecting tissues, and supporting neuroregeneration. By targeting repair mechanisms and anti-inflammatory processes without the blood-related effects of EPO, ARA-290 has attracted significant interest in the fields of regenerative medicine and biohacking.